Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252

✍ Scribed by Edith A. Perez; Vera J. Suman; Kendrith M. Rowland; James N. Ingle; Muhammad Salim; Charles L. Loprinzi; Patrick J. Flynn; James A. Mailliard; Carl G. Kardinal; James E. Krook; Abby R. Thrower; Daniel W. Visscher; Robert B. Jenkins

• Book ID: 119934729
• Publisher: CIG Media Group, LP.
• Year: 2005
• Tongue: English
• Weight: 894 KB
• Volume: 6
• Category: Article
• ISSN: 1526-8209
• DOI: 10.3816/cbc.2005.n.047